Lung Cancer, Nonsmall Cell, Stage I Active Not Recruiting Phase 2 Trials for Osimertinib (DB09330)

Also known as: NSCLC, Stage I / Stage I NSCLC / Stage I Non-Small Cell Lung Cancer / Non-small Cell Lung Cancer Stage I / Lung cancer non-small cell stage I

IndicationStatusPhase
DBCOND0081601 (Lung Cancer, Nonsmall Cell, Stage I)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03433469Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before SurgeryTreatment